Day One Biopharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Analysis

Day One Biopharmaceuticals, Inc. (DAWN)

9.18 -0.19 (-2.03%) USD | NASDAQ | Dec 30, 16:00

9.10 -0.08 (-0.87%) Pre-Market: 08:18

View Net Non-Operating Interest Income Expense (Quarterly) for DAWN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Mersana Therapeutics, Inc.	Upgrade
Iovance Biotherapeutics, Inc.	Upgrade
Lantheus Holdings, Inc.	Upgrade
iRhythm Technologies, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade